Literature DB >> 20653668

Human models of hyperalgesia and pain (chilli pepper with your acid indigestion, Sir?).

J M Ritter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20653668      PMCID： PMC2911545          DOI： 10.1111/j.1365-2125.2010.03725.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Observations on chemical excitants of cutaneous pain in man.

Authors:  D ARMSTRONG; R M L DRY; C A KEELE; J W MARKHAM
Journal:  J Physiol       Date:  1953-05-28       Impact factor: 5.182

Review 2.  How different is oxycodone from morphine?

Authors:  Eija Kalso
Journal:  Pain       Date:  2007-10-24       Impact factor: 6.961

Review 3.  Neurotrophins: mediators and modulators of pain.

Authors:  Sophie Pezet; Stephen B McMahon
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

4.  Different effects of morphine and oxycodone in experimentally evoked hyperalgesia: a human translational study.

Authors:  Anne Estrup Olesen; Camilla Staahl; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2010-08       Impact factor: 4.335

5.  The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated.

Authors:  Fraser B Ross; Maree T Smith
Journal:  Pain       Date:  1997-11       Impact factor: 6.961

Review 6.  Differences between and combinations of opioids re-visited.

Authors:  Maree T Smith
Journal:  Curr Opin Anaesthesiol       Date:  2008-10       Impact factor: 2.706

Review 7.  Assessing analgesic actions of opioids by experimental pain models in healthy volunteers - an updated review.

Authors:  Camilla Staahl; Anne Estrup Olesen; Trine Andresen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335
  7 in total
  1 in total

1.  Exploiting modern cannabinoid pharmacology for therapeutic gain?

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.